Dr. John Cush RheumNow
5 years 10 months ago
Check out our video with the Global Rheumatology Alliance Panel #ACR20
https://t.co/Q2oKx8JghT
The prospect of automating hand x-ray scoring reliably has always been an enticing one, and data presented at the American College of Rheumatology (ACR) Convergence 2020 suggest this might be in reach in the near future – opening up the prospect of automatic x-ray scoring in real-word practice, without the need for routine involvement of a specialized radiologist.
Dr. John Cush RheumNow
5 years 10 months ago
Listen to the Rheum Now discuss the topics presented at the #ACR20 meeting.
https://t.co/sd0J9ZnRpK https://t.co/RNm7HdXZtO
Dr. John Cush RheumNow
5 years 10 months ago
The #ACR20 convergence highlighted a shift in gout management and uric acid lowering therapy (ULT). Read more about mitigating immunogenicity when using uricase therapies as ULT in an article by Dr. Alexa Meara ( @lexmeara)
https://t.co/MmO224139q https://t.co/iPcf7yENWf
Rheumatology conference season always gets me excited because it means learning new information from experts, being updated on what’s hot in the f
Dr. John Cush RheumNow
5 years 10 months ago
New podcast out now on our site #ACR20
Mid-Meeting Recap: Psoriatic Arthritis, Gout Patient Outcomes on Low-Dose Steroids, Giant Cell Arteritis Panel Vaccination w/ Shingrix: Does it work for patients on JAKi? Is it safe?
https://t.co/roc1Qjec5R https://t.co/gSkkj2Kl0m
Dr. John Cush RheumNow
5 years 10 months ago
Listen to our podcast of Day 4, Part VI. Check out the recaps of topics presented at the #ACR20 meeting.
https://t.co/nAUgBJDv2B https://t.co/SPIoEMug6O
Dr. John Cush RheumNow
5 years 10 months ago
Check out this video with Dr. Dey (@DrMiniDey) on race/ethnicity associated with poor outcomes in rheum patients with COVID-19 ) #ACR20
https://t.co/ecenB2i5At
Dr. John Cush RheumNow
5 years 10 months ago
Listen to the Rheum Now podcast on Day 4 of the #ACR20 meeting.
Topics: Belimumab in Lupus Nephritis, Enthesitis in PsA, Equity & Inclusion in Rheumatology Education, Osteoarthritis Studies, Outcomes of COVID in Rheumatic Disease Patients
https://t.co/1PShHqXa0j https://t.co/9ALWsjWqpB
Dr. John Cush RheumNow
5 years 11 months ago
Listen to the Rheum Now podcast on Day 4 of the #ACR20 annual meeting.
https://t.co/Ekzl6BTiQU https://t.co/JLBdNNnnFY
Exclusive interview with Dr. David Karp, 84th ACR president
Dr. Kathryn Dao interviews the newly installed and 84th president of the American College of Rheumatology, Dr. David Karp. Dr. Karp talks about his goals for the coming year; how the work of the College continues in this unprecedented era; the role of ACR virtual education in the future; challenges ahead with regards to COVID and its impact on patients, including vaccination; and how ACR members can get involved.
Dr. John Cush RheumNow
5 years 11 months ago
COVID, Artificial Intelligence and Metabolomics at #ACR20 with Dr. Arthur Kavanaugh.
Dr. Arthur Kavanaugh provides an overview of the ACR 2020 meeting, including his review of COVID, machine learning (AI) and metabolomics sessions.
https://t.co/AalXieuRfb
Dr. John Cush RheumNow
5 years 11 months ago
Read our summary of abstract 1770 on whether the LLDAS at the start of pregnancy was predictive of pregnancy outcome. #ACR20
https://t.co/gfl7hKMDbe https://t.co/nX1qb6zHGo
Dr. John Cush RheumNow
5 years 11 months ago
Watch our video with Dr. Petryna ( @DrPetryna) as she discusses inadequate response in spondylitis. #ACR20
https://t.co/TCRoO8qGbs
Investigations on the efficacy and safety of JAK inhibitors as a therapeutic option in the management of AS are increasing.
